Navigation Links

Biology Technology

SpineFrontier Enhances the MISquito Percutaneous Pedicle Screw System in Response to Growing Demand

1/20/2017
MALDEN, MA (PRWEB) January 20, 2017 SpineFrontier, Inc., the leader in Less Exposure Surgery (LES®) Technologies, announced today the next evolution in spinal fusion, the MISquito Percutaneous Pedicle Screw System (part of the PedFuse Pedicle Screw System platform). In contrast to the co... [Comments]

Cancer Biomarkers Market - Global Opportunity Analysis and Industry Forecast 2014-2022: Omics Accounted for More Than Half of the $6.5 Billion Market - Research and Markets

1/19/2017
DUBLIN , Jan 19, 2017 Research and Markets has announced the addition of the "Cancer Biomarkers Market by Profiling Technology, Biomolecules, Cancer Type, Application - Global Opportunity Analysis and Industry Forecast, 2014-2022" report to their offering. Cancer Biomarkers Market Report, forecasts that the global market is projected to reach $15,737 mi... [Comments]

Liquid Biopsy Market is Predicted to Grow at a CAGR of 21.6% from 2016 to 2022

1/19/2017
PUNE, India , Jan. 19, 2017  Market Research Future has a half cooked research report on Global Liquid Biopsy Market. The Global Market for Liquid Biopsy is growing rapidly and expected to reach USD 450 Million by the end of the forecasted period. Market Highlights The Global Liquid Biopsy Market has been assessed as a swiftly growing market and expect... [Comments]

NX Prenatal Appoints Leading Experts to Medical/Clinical Advisory Board

1/19/2017
LOUISVILLE, Ky. and HOUSTON , Jan. 19, 2017 NX Prenatal Inc. ("NX Prenatal") today announced the formation of its Medical/Clinical Advisory Board.  This new board brings together leading clinicians and industry veterans who enhance the range and depth of expertise of the company as it accelerates development of its novel prenatal diagnostic tests.  These experts... [Comments]

WuXi AppTec Acquires Biology Focused R&D Service Leader HD Biosciences

1/19/2017
SHANGHAI , Jan. 19, 2017 /PRNewswire -- WuXi AppTec, a leading global pharmaceutical, biotechnology and medical device open-access capability and technology platform, today announced that it has acquired HD Biosciences (HDB), a leading biology focused preclinical drug discovery contract research organization (CRO). After completion of acquisition, HD Biosciences will become a wholly-owned sub... [Comments]

Implantable Biomaterials Market Material, Application Analysis & Trends 2016-2025: $150+ Billion Growth Opportunities/Investment Opportunities - Research and Markets

1/19/2017
DUBLIN , Jan 19, 2017 Research and Markets has announced the addition of the "Implantable Biomaterials Market Analysis & Trends - Material, Application - Forecast to 2025" report to their offering. Report Highlights: The report provides a detailed analysis on current and future market trends to identify the investment opportunities... [Comments]

Genedata Launches Data Science Services for Precision Medicine

1/19/2017
Basel, Switzerland (PRWEB) January 19, 2017 Genedata, a leading provider of advanced software solutions for pharmaceutical research and development (R&D), today announced the launch of Data Science Services , offering on-demand, project-based expertise in omic data analysis and interpret... [Comments]

November Research Group Announces the Availability of PRIMO Mail

1/19/2017
Berkeley, CA (PRWEB) January 19, 2017 November Research Group, LLC, a global leader in the delivery of product vigilance software to leading biopharmaceutical and medical device manufacturers and regulators, is proud to announce the worldwide release of PRIMO Mail. PRIMO Mail is a fully 21 CF... [Comments]

PharmAthene and Altimmune Announce Merger to Create Immunotherapeutics Company Targeting Infectious Diseases

1/19/2017
ANNAPOLIS, Md. and GAITHERSBURG, Md. , Jan. 19, 2017  PharmAthene, Inc. (NYSE MKT: PIP) and Altimmune, Inc., a privately-held immunotherapeutics company targeting infectious diseases, announced today the signing of a definitive agreement for the merger of PharmAthene and Altimmune in an all-stock transaction. Altimmune's current investors include Novartis Venture Fund,... [Comments]

ArmaGen Appoints Mathias Schmidt, Ph.D., as Chief Executive Officer

1/19/2017
CALABASAS, Calif. , Jan. 19, 2017  ArmaGen, Inc., today announced that it has appointed Mathias Schmidt , Ph.D., as chief executive officer, as well as a member of ArmaGen's board of directors. Dr. Schmidt brings to ArmaGen more than 17 years of executive management experience focused on the research and development of biotherapeutics and pharmaceuticals. "Mathias... [Comments]

AquaBounty Announces Completion of NASDAQ Listing and Equity Subscription from Intrexon

1/19/2017
MAYNARD, Mass. , Jan. 19, 2017 AquaBounty Technologies, Inc. (AIM: ABTU; NASDAQ: AQB), a biotechnology company focused on enhancing productivity in aquaculture and a majority-owned subsidiary of Intrexon Corporation (NYSE: XON ), announces that it has completed the listing of its common shares on the NASDAQ Stock Market and finalized the equity subscription from Intrexon.... [Comments]

Medicine Technology

Die internationale humanitäre Stadt Dubai soll ihren Umfang verdreifachen

1/20/2017
DUBAI , VAE, January 20, 2017 Entscheidung fällt als Reaktion auf den stark gestiegenen Bedarf an Nothilfe   Die internationale humanitäre Stadt soll um knapp 2800 m² erweitert werden, um Platz für Hilfsgüter zu schaffen   Seine Hoheit Scheich Muhammad bin Raschid Al Maktum, Vizepräsident und Premierminister der VAE sowie Herrscher von Duba... [Comments]

Avillion Strengthens Clinical and Regulatory Development Capabilities with the Appointment of Mark Weinberg as Chief Medical Officer

1/20/2017
LONDON , January 20, 2017 Avillion LLP, a co-developer and financier of late-stage pharmaceutical product candidates, announces the appointment of Mark Weinberg , MD MBA as Chief Medical Officer. Dr Weinberg will be based in Chicago , USA . Dr Weinberg has spent more than 17 years as a pharmaceutical and biotech executive with experience ranging fro... [Comments]

Germany Cataract Surgery Devices Market Outlook to 2022

1/19/2017
LONDON , Jan. 19, 2017 Germany Cataract Surgery Devices Market Outlook to 2022 Summary GlobalData's new report, "Germany Cataract Surgery Devices Market Outlook to 2022", provides key market data on the Germany Cataract Surgery Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segements - Phacoem... [Comments]

Immunomodulators Market Analysis By Product (Immunosuppressant, Immunostimulants, Vaccines, Antibodies), By Application (Oncology, Respiratory, HIV), By Region, And Segment Forecasts, 2014 - 2025

1/19/2017
NEW YORK , Jan. 19, 2017 The global immunomodulators market is expected to reach USD 233.7 billion by 2025, according to a new study by Grand View Research, Inc. The market is anticipated to be predominantly driven by high R&D investments employed by the prominent companies, resulting into the large-scale production of new and therapeutically advanced drugs. This is believ... [Comments]

Ophthalmic Devices Market Forecast 2016-2026: Clarifying Vision - Prospects and Developments in Ophthalmic Surgical Devices, Diagnostics and Monitoring, and Vision Care

1/19/2017
NEW YORK , Jan. 19, 2017 Report Details What can be expected from the Ophthalmic Devices Market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects. Our 190-page report provides 124 tables, charts, and graphs. Discover the most lucrative areas in the industry an... [Comments]

Global Non-Small Cell Lung Cancer Partnering 2010 to 2016

1/19/2017
NEW YORK , Jan. 19, 2017 The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed by company A-Z, industry sector, stage of development, technology type The report provides... [Comments]

FDA approves Trulance for Chronic Idiopathic Constipation

1/19/2017
SILVER SPRING, Md. , Jan. 19, 2017 The U.S. Food and Drug Administration today approved Trulance (plecanatide) for the treatment of Chronic Idiopathic Constipation (CIC) in adult patients. "No one medication works for all patients suffering from chronic gastrointestinal disorders," said Julie Beitz , M.D., director of the Office of Drug Evaluation III in the FDA... [Comments]

Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2016 Financial Results on February 15, 2017

1/19/2017
WASHINGTON , Jan. 19, 2017 Conference Call and Webcast to Follow Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ) today announced it will release results for the fourth quarter of 2016 on Wednesday, February 15, 2017, after the market closes. Vanda will host a conference call at 4:30 PM ET on Wednesday, February 15, 2017, during which management will... [Comments]

Alzheimer's Disease Therapeutics and Diagnostics Market Forecast 2016-2026: Opportunities for Leading Companies

1/19/2017
NEW YORK , Jan. 19, 2017 Report Details Alzheimer's Disease Therapeutics and Diagnostics Market Forecast 2016-2026: Opportunities for Leading Companies – our new study reveals trends, R&D progress, and predicted revenues Our new report discusses issues and events affecting the Alzheimer's disease therapeutics and diagnostics market. Our new report provid... [Comments]

Opioid Induced Constipation Treatment Market:: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023

1/19/2017
NEW YORK , Jan. 19, 2017 This report on the opioid induced constipation treatment market studies the current and future scenario of the global market. Large number of chronic pain sufferers is responsible for rising opioid consumption. Severe chronic constipation is a major side effect of consumption of opioid and shows resistance to traditional laxatives. Hence, novel targete... [Comments]

Medicationdiscountcard.com Launches New Online Feature for Comparison Shopping of Prescription Drugs

1/19/2017
ATLANTIC CITY, N.J. , Jan. 19, 2017 Many patients don't realize that they may be paying over $100 for their medication when a pharmacy just a few blocks away charges only $25 for the same exact prescription.  To alleviate this problem Medicationdiscountcard.com has created a price comparison engine allowing doctors and patients to see exactly how much their medication w... [Comments]

(Date:1/19/2017)... Research and Markets has announced the addition ... Type, Application - Global Opportunity Analysis and Industry Forecast, 2014-2022" ... ... is projected to reach $15,737 million by 2022 from $6,521 in ... Omic technologies segment accounted for more than half ...
(Date:1/19/2017)... , Jan. 19, 2017 /PRNewswire -- WuXi ... device open-access capability and technology platform, today announced ... leading biology focused preclinical drug discovery contract research ... will become a wholly-owned subsidiary of WuXi, and ... competences and providing greater services. The acquisition will ...
(Date:1/19/2017)... ... January 19, 2017 , ... November Research Group, LLC, a ... medical device manufacturers and regulators, is proud to announce the worldwide release of ... designed to provide product vigilance departments with the flexibility and ease of use ...
(Date:1/19/2017)... , Jan. 19, 2017 AquaBounty Technologies, ... on enhancing productivity in aquaculture and a majority-owned subsidiary ... that it has completed the listing of its common ... equity subscription from Intrexon. "AquaBounty,s listing on ... will broaden our exposure to the U.S. markets as ...
Breaking Biology Technology:
(Date:1/19/2017)... CLEVELAND , Jan. 19, 2017 ViewRay, ... (DFG), a federal institution supporting research in ... installation and patient treatments at the University Clinic Heidelberg ... The MRIdian Linac program will be headed ... who also heads radiation oncology at the German Cancer ...
(Date:1/19/2017)... CAMBRIDGE, England , January 19, 2017 ... MedImmune and Otsuka in the Milner Therapeutics Consortium   ... academic scientists in Cambridge   ... Inc. (NYSE: PFE ) as a partner ... join the Consortium, which enables the efficient transfer of ...
(Date:1/19/2017)... global  pacemaker market  is expected to reach USD 12.3 billion by 2025, according ... cardiac conditions coupled with the availability of medical coverage is a key driving ... devices are supporting the expansion of this vertical. ... ... Logo ...
Breaking Medicine Technology: